ACHAOGEN INC

Profile

Company Names

ACHAOGEN INC

Addresses

1 TOWER PL, SUITE 300, SOUTH SAN FRANCISCO, CA 94080

7000 SHORELINE COURT, SUITE 371, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

650-800-3636
650-266-1120

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$89,716,543.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2017-05-05 
$9,999,976.00 
$9,999,976.00 
$0.00 
Equity 
3
2016-06-03 
$25,449,987.00 
$32,769,984.00 
$7,319,997.00 
Equity 
2
2013-03-06 
$18,905,707.00 
$30,683,703.00 
$11,777,996.00 
Equity 
1
2010-04-06 
$35,360,873.00 
$56,413,706.00 
$21,052,833.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JON 
B. 
BRUSS 
EXECUTIVE OFFICER
ACHAOGEN INC
ALAN 
B. 
COLOWICK 
DIRECTOR
GLOUCESTER PHARMACEUTICALS INC   |  ACHAOGEN INC   |  ALUMIS INC.
TROY 
 
COX 
DIRECTOR
ACHAOGEN INC
JOHN 
 
DOYLE 
DIRECTOR
ACHAOGEN INC   |  PNC REAL ESTATE TAX CREDIT CAPITAL INSTITUTIONAL FUND 56 LLC   |  OJAI NATURAL FOODS, INC.   |  PULSE OIL CORP.   |  ALEDADE, INC.   |  PRIVATE TECH INC.
JOHN 
C. 
DOYLE 
DIRECTOR, EXECUTIVE OFFICER
ACHAOGEN INC
BECKI 
 
FILICE 
EXECUTIVE OFFICER
ACHAOGEN INC
MICHAEL 
 
FISCHBACH 
DIRECTOR
ACHAOGEN INC   |  KELONIA THERAPEUTICS, INC.
IAN 
R. 
FRIEDLAND 
EXECUTIVE OFFICER
ACHAOGEN INC
HALLEY 
E. 
GILBERT 
DIRECTOR
ACHAOGEN INC
KENNETH 
J. 
HILLAN 
EXECUTIVE OFFICER, DIRECTOR
ACHAOGEN INC
JOHN 
F. 
HOLLWAY 
EXECUTIVE OFFICER
ACHAOGEN INC
DENNIS 
 
HOM 
EXECUTIVE OFFICER
ACHAOGEN INC   |  3-V BIOSCIENCES, INC.   |  SAGIMET BIOSCIENCES INC.
J. KEVIN 
 
JUDICE 
EXECUTIVE OFFICER, DIRECTOR
ACHAOGEN INC
THOMAS 
 
KING 
DIRECTOR
THERMASOURCE LLC   |  ACHAOGEN INC   |  ENERGYSAVVY INC   |  FARADAY PHARMACEUTICALS, INC.   |  CONCENTRIC ANALGESICS, INC.   |  SATSUMA PHARMACEUTICALS, INC.   |  LIMIVOROUS PREFERRED FUND LP   |  TFF PHARMACEUTICALS, INC.   |  BLACK ICE DATA INC.
KENT 
 
LIEGINGER 
DIRECTOR
ACHAOGEN INC
KENT 
E. 
LIEGINGER 
DIRECTOR
ACHAOGEN INC
GARY 
 
LOEB 
EXECUTIVE OFFICER
AMYRIS, INC.   |  ACHAOGEN INC
ROBERT 
 
MORE 
DIRECTOR
OCEANA THERAPEUTICS, INC.   |  CARTICEPT MEDICAL INC   |  NUON THERAPEUTICS INC   |  ACHAOGEN INC   |  PIVOT MEDICAL INC   |  MOXIMED, INC   |  PATIENTKEEPER INC   |  FRAZIER HEALTHCARE VII-A, L.P.   |  SIENNA LABS, INC.   |  AFFINIVAX, INC.   |  VIR BIOTECHNOLOGY, INC.   |  TYRA BIOSCIENCES, INC.
HEINZ 
E. 
MOSER 
EXECUTIVE OFFICER
ACHAOGEN INC
KENNETH 
 
NUSSBACHER 
DIRECTOR
FLUIDIGM CORP   |  ACHAOGEN INC
BRYAN 
 
ROBERTS 
DIRECTOR
VITAE PHARMACEUTICALS, INC   |  VENTANA HEALTH SERVICES, INC.   |  INTARCIA THERAPEUTICS, INC   |  CASTLIGHT HEALTH, INC.   |  TANDEM TECHNOLOGIES, INC.   |  SURFACE LOGIX INC   |  POWERVISION, INC.   |  CODERYTE INC   |  KYRUUS, INC.   |  ARIA DIAGNOSTICS, INC.   |  ACHAOGEN INC   |  FATE THERAPEUTICS INC   |  ADVANCE MEDICAL, LTD.   |  BELLEROPHON THERAPEUTICS LLC   |  MUSE BIOTECHNOLOGY, INC.   |  STRIDE HEALTH, INC.   |  DEVOTED HEALTH, INC.   |  INSCRIPTA, INC.   |  LYRA HEALTH, INC.   |  PSY THERAPEUTICS, INC.   |  MYTHIC THERAPEUTICS, INC.   |  SITKA, INC./DELAWARE   |  PUBLIC HEALTH CO GROUP, INC.   |  GRAND ROUNDS, INC.   |  SMITH HEALTH, INC.   |  KELONIA THERAPEUTICS, INC.   |  JW CELTICS INVESTMENT CORP.   |  ACCOMPANY HEALTH, INC.
BRYAN 
E. 
ROBERTS 
DIRECTOR
CERULEAN PHARMA INC.   |  IRONWOOD PHARMACEUTICALS INC   |  IKARIA HOLDINGS INC   |  FATE THERAPEUTICS INC   |  ACHAOGEN INC   |  VENROCK ASSOCIATES VI, L.P.   |  VENROCK PARTNERS VI, L.P.   |  VENROCK ASSOCIATES VII, L.P.   |  VENROCK ASSOCIATES VIII, L.P.   |  VENROCK ASSOCIATES IX, L.P.   |  VENROCK ASSOCIATES X, L.P.   |  VENROCK PARTNERS X, L.P.
SCOTT 
 
ROCKLAGE 
DIRECTOR
RENNOVIA INC   |  PULMATRIX INC   |  5AM CO-INVESTORS III, L.P.   |  ACHAOGEN INC   |  RELYPSA INC   |  WAVERX INC   |  SEMPRUS BIOSCIENCES CORP   |  VARIATION BIOTECHNOLOGIES (US), INC.   |  KINESTRAL TECHNOLOGIES, INC.   |  NOVIRA THERAPEUTICS, INC.   |  5AM CO-INVESTORS IV, L.P.   |  K2 THERAPEUTICS, INC.   |  CIDARA THERAPEUTICS, INC.   |  PULMATRIX OPERATING COMPANY, INC.   |  PULMATRIX, INC.   |  EXPANSION THERAPEUTICS, INC.   |  ALBAMUNITY, INC.
CAMILLE 
 
SAMUELS 
DIRECTOR
SEMPRAE LABORATORIES INC   |  KYTHERA BIOPHARMACEUTICALS INC   |  ACHAOGEN INC   |  SPIROX, INC.   |  REGENXBIO INC.   |  UNITY BIOTECHNOLOGY, INC.   |  BIOLUX RESEARCH HOLDINGS, INC.   |  XCALIBER BIOTECHNOLOGY, INC.   |  OCELOT BIO, INC.   |  MAHZI THERAPEUTICS INC.
CAMILLE 
D. 
SAMUELS 
DIRECTOR
ACHAOGEN INC   |  VERSANT SIDE FUND II, LP   |  VENROCK ASSOCIATES VIII, L.P.   |  VENROCK ASSOCIATES IX, L.P.
ZERYN 
 
SARPANGAL 
EXECUTIVE OFFICER
ACHAOGEN INC
TOBIN 
C. 
SCHILKE 
EXECUTIVE OFFICER
ACHAOGEN INC
JOHN 
W. 
SMITHER 
DIRECTOR
ACHAOGEN INC   |  EFFECTOR THERAPEUTICS, INC.
GREGORY 
 
STEA 
DIRECTOR
ACHAOGEN INC
LEE 
 
SWEM 
EXECUTIVE OFFICER
ACHAOGEN INC
CHRISTOPHER 
 
WALSH 
DIRECTOR
ACHAOGEN INC   |  WPJ HOLDINGS, INC.   |  PROTEOSTASIS THERAPEUTICS, INC.   |  ACADIASOFT INC   |  PROACTIVE LIVING   |  PROACTIVE LIVING, LLC   |  PROACTIVE LIVING, INC   |  INTEGRITY IMPLANTS INC.   |  ANTLER SPECIAL OPPORTUNITIES FUND II LP
CHRISTOPHER 
T. 
WALSH 
DIRECTOR
IRONWOOD PHARMACEUTICALS INC   |  PROTEOSTASIS THERAPEUTICS INC   |  PROTEOSTASIS THERAPEUTICS, INC.   |  ACHAOGEN INC
CHRISTINE 
 
WELCH 
EXECUTIVE OFFICER
ACHAOGEN INC
BLAKE 
 
WISE 
EXECUTIVE OFFICER
ACHAOGEN INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-05-16
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-05-05 
2016-06-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-06-03 
2013-03-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-06 
2010-04-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#